| Title |
Implication of Cannabinoids in Neurological Diseases
|
|---|---|
| Published in |
Cellular and Molecular Neurobiology, May 2006
|
| DOI | 10.1007/s10571-006-9070-8 |
| Pubmed ID | |
| Authors |
Angela Alsasua del Valle |
| Abstract |
1. Preparations from Cannabis sativa (marijuana) have been used for many centuries both medicinally and recreationally. 2. Recent advances in the knowledge of its pharmacological and chemical properties in the organism, mainly due to Delta(9)-tetrahydrocannabinol, and the physiological roles played by the endocannabinoids have opened up new strategies in the treatment of neurological and psychiatric diseases. 3. Potential therapeutic uses of cannabinoid receptor agonists include the management of spasticity and tremor in multiple sclerosis/spinal cord injury, pain, inflammatory disorders, glaucoma, bronchial asthma, cancer, and vasodilation that accompanies advanced cirrhosis. CB(1) receptor antagonists have therapeutic potential in Parkinson's disease. 4. Dr. Julius Axelrod also contributed in studies on the neuroprotective actions of cannabinoids. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | 1% |
| United Kingdom | 1 | 1% |
| Iran, Islamic Republic of | 1 | 1% |
| Spain | 1 | 1% |
| United States | 1 | 1% |
| Unknown | 82 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 14 | 16% |
| Researcher | 11 | 13% |
| Student > Master | 9 | 10% |
| Other | 8 | 9% |
| Student > Ph. D. Student | 8 | 9% |
| Other | 19 | 22% |
| Unknown | 18 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 28% |
| Agricultural and Biological Sciences | 8 | 9% |
| Nursing and Health Professions | 7 | 8% |
| Neuroscience | 7 | 8% |
| Biochemistry, Genetics and Molecular Biology | 6 | 7% |
| Other | 16 | 18% |
| Unknown | 19 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2017.
All research outputs
#4,405,499
of 23,854,458 outputs
Outputs from Cellular and Molecular Neurobiology
#178
of 1,046 outputs
Outputs of similar age
#10,970
of 67,613 outputs
Outputs of similar age from Cellular and Molecular Neurobiology
#1
of 13 outputs
Altmetric has tracked 23,854,458 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,046 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,613 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.